Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Metabolism01:19

Regulation of Metabolism

11.3K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
11.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.2K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.5K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.5K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Mobilization with Mechanical Axis Preservation: A Prospective Outcome Analysis of Titanium Elastic Nailing in Femoral Shaft Fractures of School-Aged Children.

Journal of orthopaedic case reports·2026
Same author

Microbial proteases and endothelial barrier disruption in sepsis: A neglected nexus.

Virulence·2026
Same author

Immunomodulator drugs: Mechanism of action and systemic effects.

Advances in protein chemistry and structural biology·2026
Same author

Integration of Metabolic Pathways and Micronutrient Signals Influences Neurodevelopment by Modulating Neural Stem Cell Dynamics.

Molecular neurobiology·2026
Same author

The gut microbiome axis: how Lactobacillus-fermented soymilk orchestrates health.

Archives of microbiology·2026
Same author

Timing of transfer to a tertiary care center and early surgical outcome of obstructed total anomalous pulmonary venous connection in resource-limited settings.

Annals of pediatric cardiology·2026

Related Experiment Video

Updated: Jan 7, 2026

Analysis of Hematopoietic Stem Progenitor Cell Metabolism
12:20

Analysis of Hematopoietic Stem Progenitor Cell Metabolism

Published on: November 9, 2019

7.3K

MitomiRs as Key Players in Metabolic Reprogramming of Blood Cell Development.

Vijay Prasad Koppineedi1, Mahesh Gutti2, Bheriprasad Padhan1

  • 1Department of Biochemistry, School of Life Sciences, University of Hyderabad, Gachibowli, Hyderabad, India.

Experientia Supplementum (2012)
|January 1, 2026
PubMed
Summary

Mitochondrial microRNAs (MitomiRs) regulate gene expression and cellular functions in blood cell development. This chapter explores their role in metabolic reprogramming and potential therapeutic applications.

Keywords:
Hematopoietic stem cellsMetabolic reprogrammingMetabolismMitochondrial miRNA or mitomiRsand Blood cell developmentmiRNAs

More Related Videos

Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry
07:57

Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry

Published on: December 26, 2019

12.9K
Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps
07:17

Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps

Published on: July 30, 2019

8.3K

Related Experiment Videos

Last Updated: Jan 7, 2026

Analysis of Hematopoietic Stem Progenitor Cell Metabolism
12:20

Analysis of Hematopoietic Stem Progenitor Cell Metabolism

Published on: November 9, 2019

7.3K
Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry
07:57

Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry

Published on: December 26, 2019

12.9K
Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps
07:17

Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps

Published on: July 30, 2019

8.3K

Area of Science:

  • Mitochondrial biology
  • Gene regulation
  • Hematopoiesis

Background:

  • Mitochondria are central to cellular metabolism.
  • MicroRNAs (miRNAs) are key regulators of gene expression.
  • Mitochondrial miRNAs (MitomiRs) are emerging as critical players in cellular processes.

Purpose of the Study:

  • To discuss the role of MitomiRs in metabolic reprogramming during blood cell formation.
  • To explore the biosynthesis and function of MitomiRs in hematopoiesis.
  • To consider the therapeutic potential of MitomiRs.

Main Methods:

  • Literature review and synthesis of current research on MitomiRs.
  • Analysis of MitomiR involvement in mitochondrial gene expression.
  • Examination of MitomiR impact on cellular functions during blood cell development.

Main Results:

  • MitomiRs are present and active in blood cells.
  • MitomiRs influence mitochondrial gene expression.
  • MitomiRs affect oxidative stress, energy production, and apoptosis in developing blood cells.

Conclusions:

  • MitomiRs significantly modulate cellular functions during blood cell development.
  • Understanding MitomiRs opens new avenues for therapeutic interventions in hematological disorders.
  • Further research into MitomiR biosynthesis and function is warranted.